J 0017/12 vom 13.11.2013
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2013:J001712.20131113
- Datum der Entscheidung
- 13. November 2013
- Aktenzeichen
- J 0017/12
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 03781836.6
- IPC-Klasse
- A61K 38/11A61P 13/00
- Verfahrenssprache
- Englisch
- Verteilung
- An die Kammervorsitzenden verteilt (C)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN
- Name des Antragstellers
- Allergan, Inc.
Third party:
Ferring BV - Name des Einsprechenden
- -
- Kammer
- 3.1.01
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 112(1)European Patent Convention Art 61(1)European Patent Convention Art 71European Patent Convention Art 74European Patent Convention R 14(1)European Patent Convention R 14(3)European Patent Convention R 21(1)European Patent Convention R 21(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Schlagwörter
- Reversal of entry of applicant in register (yes)
Continuation of appeal proceedings with wrong parties (no)
Referral to the Enlarged Board of Appeal - (no) - Orientierungssatz
- The transfer of a European patent application may not be recorded in the European Patent Register at a time when proceedings for the grant of the application are stayed under Rule 14(1) EPC.
Order
For these reasons it is decided that:
For the above reasons it is decided that:
1. The decision under appeal (cf. point 4 of the decision dated 25 May 2012) is set aside.
2. The registration of Allergan as applicant is ordered to be reversed.
3. The appeal of Allergan is dismissed.
4. Allergan's requests to refer three questions to the Enlarged Board of Appeal are refused.